Results 211 to 220 of about 37,679 (288)
Impact of female genital mutilation laws, policies, and professional codes of conduct on healthcare workers' knowledge, attitudes, skills, and quality of care: A mixed-method review. [PDF]
Asaolu I +8 more
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Distinguishing social and medical traits: perspectives of scientists using polygenic scores. [PDF]
Waltz M +6 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
What can complex systems theory reveal about social inclusion. [PDF]
Speyer H.
europepmc +1 more source
Review of \u27Development and Public Health in the Himalaya: Reflections on Healing in Contemporary Nepal\u27 by Ian Harper [PDF]
Folmar, Steve
core +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
A problematic view of peer review; the epistemic distance of medical humanities with medicine. [PDF]
Ravan N, Namazi H.
europepmc +1 more source

